1 follower
InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together wi... Read more
Kura Oncology
20 followers
Dyne Therapeutics
3 followers
Precigen
3 followers
Arcturus Therapeutics
2 followers
Biocytogen
2 followers
Gamida Cell
2 followers
Fortis Life Sciences
1 follower
Entrada Therapeutics
1 follower
Cabaletta Bio
1 follower
Janux Therapeutics
1 follower
Matica Biotechnology
1 follower
Explore companies